نتایج جستجو برای: ژن myh9

تعداد نتایج: 16127  

ژورنال: :فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران 0
پوپک بهزاد poopak b faculty of medicine, islamic azad university, tehran medical unitدانشکده پزشکی، دانشگاه آزاد اسلامی، واحد پزشکی تهران یحیوی سیدحسین yahyavi sh faculty of medicine, islamic azad university, tehran medical unitدانشکده پزشکی، دانشگاه آزاد اسلامی، واحد پزشکی تهران حق نژاددوشانلو فریبا haghnejad doshanlo f faculty of medicine, islamic azad university, tehran medical unitدانشکده پزشکی، دانشگاه آزاد اسلامی، واحد پزشکی تهران رضوانی حمید rezvani h departmen t of hematology-oncology, taleghani hospital, shaheed beheshti university of medical sciencesبخش هماتولوژی، بیمارستان آیت ا... طالقانی، دانشگاه علوم پزشکی شهید بهشتی مارتیگتی جان martignetti j departments of human genetics , mount sinai school of medicine, new york, usaگروه ژنتیک انسانی، دانشکده پزشکی mount siani، نیویورک، آمریکا دیفئو آنالیزا difeo a departments of human genetics , mount sinai school of medicine, new york, usaگروه ژنتیک انسانی، دانشکده پزشکی mount siani، نیویورک، آمریکا خسروی پور گلاره

آنومالی may-hegglin یک اختلال نادر اتوزومال غالب است که با تریاد کاهش پلاکت، پلاکت های بزرگ و اجسام شبیه دوهل در گرانولوسیتها مشخص می گردد. .هدف از این بررسی گزارش اولین مورد نارسایی در ایران و تعیین نوع موتاسیون مربوطه است. در این بررسی آزمایش cbc و گستره خون محیطی دو بیمار از یک خانواده (پدر و پسر) که به ترتیب 51 و 15 ساله بودند با دو ضدانعقاد edta و سیترات تری سدیم با شمارنده خودکار و بررسی ...

Journal: :Thrombosis and haemostasis 2010
Anna Savoia Daniela De Rocco Emanuele Panza Valeria Bozzi Raffaella Scandellari Giuseppe Loffredo Andrew Mumford Paula G Heller Patrizia Noris Marco R De Groot Marisa Giani Paolo Freddi Francesca Scognamiglio Silvia Riondino Núria Pujol-Moix Fabrizio Fabris Marco Seri Carlo L Balduini Alessandro Pecci

MYH9-related disease ( MYH9-RD) is an autosomal dominant thrombocytopenia with giant platelets variably associated with young-adult onset of progressive sensorineural hearing loss, presenile cataract, and renal damage. MYH9-RD is caused by mutations of MYH9 , the gene encoding for non-muscle heavy-chain myosin-9. Wild-type and mutant myosin-9 aggregate as cytoplasmic inclusions in patients' leu...

Journal: :Molecular pharmacology 2006
Karin Kohlstedt Roland Kellner Rudi Busse Ingrid Fleming

The phosphorylation of the short C-terminal cytoplasmic domain of the somatic angiotensin-converting enzyme (ACE) is involved in the regulation of enzyme shedding. We determined whether the phosphorylation of the cytoplasmic domain of ACE (ACEct) on Ser1270 regulates the cleavage/secretion of the enzyme by affecting its association with other proteins. ACE was associated with beta-actin and the...

2017
Rengeng Liu Qianyu Zhang Yuehong Lang Zibo Tang Zhongzhong Peng Xiaojun Cai Zhaojian Fu Weiyi Fang Libo Li

MYH9 (myosin, heavy chain 9, non-muscle) as a gene encodes NM II-A (non-muscle II-A) protein, exists primarily in the cytoplasm. MYH9 consists of 2 mysoin heavy chains with a relative molecular mass of 230 kDa. Previous studies have shown that MYH9 is involved in a number of diseases, including cancer. However, the exact role of MYH9 in colon cancer is still unclear. Therefore, we used a tissue...

2012
Ken Katono Yuichi Sato Shi-Xu Jiang Makoto Kobayashi Ryo Nagashio Shinichiro Ryuge Eriko Fukuda Naoki Goshima Yukitoshi Satoh Makoto Saegusa Noriyuki Masuda

INTRODUCTION Myosin-9 (MYH9) belongs to the myosin superfamily of actin-binding motor protein. Recently, MYH9 has been thought to be associated with cancer cell migration, invasion, and metastasis. The aims of this study were to immunohistochemically examine MYH9 expression in surgically resected non-small cell lung cancer (NSCLC), and evaluate its correlations with clinicopathological paramete...

2017
Mengxia Yu Jinghan Wang Zhijuan Zhu Chao Hu Qiuling Ma Xia Li Xiufeng Yin Jiansong Huang Ting Zhang Zhixin Ma Yile Zhou Chenying Li Feifei Chen Jian Chen Yungui Wang Hanzhang Pan Dongmei Wang Jie Jin

MYH9 expression has previously been demonstrated as an independent predictor of clinical outcome in solid tumors. However, the prognostic relevance of MYH9 expression in acute myeloid leukemia is still unclear. Here, we found high MYH9 expressers were seen more frequently in females and more frequently in M4 morphology. We also found high MYH9 expressers had lower percentage of bone marrow blas...

2012
Catherine Léon Katja Evert Frank Dombrowski Fabien Pertuy Anita Eckly Patricia Laeuffer Christian Gachet Andreas Greinacher

Macrothrombocytopenia in MYH9-related disease (MYH9-RD) results from defects in nonmuscular myosin-IIA function. Thrombopoietin receptor agonists (eltrombopag; romiplostim) seem to improve hemostasis, but little is known about their biologic effects in MYH9-RD. We administered romiplostim to Myh9 / mice (100 g/kg, every 3 days, during 1 month). MKs increased to similar numbers in Myh9 / and wil...

Journal: :Blood 2012
Catherine Léon Katja Evert Frank Dombrowski Fabien Pertuy Anita Eckly Patricia Laeuffer Christian Gachet Andreas Greinacher

Macrothrombocytopenia in MYH9-related disease (MYH9-RD) results from defects in nonmuscular myosin-IIA function. Thrombopoietin receptor agonists (eltrombopag; romiplostim) seem to improve hemostasis, but little is known about their biologic effects in MYH9-RD. We administered romiplostim to Myh9(-/-) mice (100 μg/kg, every 3 days, during 1 month). MKs increased to similar numbers in Myh9(-/-) ...

2014
Alessandro Pecci Eva JJ Verver Nicole Schlegel Pietro Canzi Carlos M Boccio Helen Platokouki Eike Krause Marco Benazzo Vedat Topsakal Andreas Greinacher

BACKGROUND MYH9-related disease (MYH9-RD) is a rare syndromic disorder deriving from mutations in MYH9, the gene for the heavy chain of non-muscle myosin IIA. Patients present with congenital thrombocytopenia and giant platelets and have a variable risk of developing sensorineural deafness, kidney damage, presenile cataract, and liver abnormalities. Almost all MYH9-RD patients develop the heari...

2013
Nobuaki Suzuki Shinji Kunishima Makoto Ikejiri Shoichi Maruyama Michihiko Sone Akira Takagi Masahito Ikawa Masaru Okabe Tetsuhito Kojima Hidehiko Saito Tomoki Naoe Tadashi Matsushita

Nonmuscle myosin heavy chain IIA (NMMHCIIA) encoded by MYH9 is associated with autosomal dominantly inherited diseases called MYH9 disorders. MYH9 disorders are characterized by macrothrombocytopenia and very characteristic inclusion bodies in granulocytes. MYH9 disorders frequently cause nephritis, sensorineural hearing disability and cataracts. One of the most common and deleterious mutations...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید